医学
结肠炎
中止
显微镜下结肠炎
胃肠病学
炎症性肠病
内科学
药品
溃疡性结肠炎
疾病
药理学
作者
Shadi Hamdeh,Dejan Mićić,Stephen B. Hanauer
标识
DOI:10.1016/j.cgh.2020.04.069
摘要
Drug-induced colitis encompasses a wide spectrum of colon disorders that can manifest microscopically or macroscopically. Patients present with new-onset colitis or exacerbations of inflammatory bowel diseases; in some cases, colitis resolves with discontinuation of medication. Mucosal injury can be focal or extensive, involving the entire colonic mucosa, and sometimes involves other parts of the gastrointestinal tract. It has been a challenge to determine the proportion of new-onset colitis caused by medication and there are few data on the overall prevalence. We review the drugs that have been linked with development of drug-induced colitis and strategies for physicians who believe their patients have this disorder—usually discontinuation of the drug believed to cause colitis and treatment with steroids or immune-modulating therapies. Physicians must be aware of medications that can cause colitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI